This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com
Dallas, TX (PRWEB) November 27, 2012
The judge overseeing litigation of Pradaxa bleeding lawsuits recently ordered manufacturer Boehringer Ingelheim to produce evidence against safety claims by December 17th, according to a Case Management Order on November 21, 2012.*
The order comes as the latest report from the Judicial Panel on MultiDistrict Litigation on November 14, 2012 shows the number of Pradaxa internal bleeding cases has increased 50% since September 5th.*
On October 3, 2012, the Institute for Safe Medicine Practices’ QuarterWatch (PDF) estimated that prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase.
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible.
Researchers disagree on the safety of Pradaxa. The Journal for The American Medical Association warned on September 3, 2012 that the FDA may have rushed its approval, overlooking key Pradaxa side effects like internal bleeding. In its latest study released November 4, 2012, however, the FDA stated that, for now, Pradaxa carries the same risk as other blood thinners.
While all anticoagulants can cause internal bleeding, the Journal of Neurosurgery reported doctors’ concerns on March 6, 2012 that, once Pradaxa causes internal bleeding, there is little they can do to stop it.
Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. Judge Herndon ordered on July 24, 2012 that those injured by Pradaxa can proceed with lawsuits.
Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com. You may be eligible to file a Pradaxa lawsuit.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-bleeding/side-effects-lawsuit/prweb10171395.htm